You searched for "Erectile"

709 results found

BSUG (British Society of Urogynaecology) Annual Scientific Update in Urogynaecology

This event will combine the latest updates and innovations in current and emerging issues in urogynaecology. This hybrid event is an excellent opportunity for healthcare professionals with an interest in urogynaecology to improve their skills, hear current practice dilemmas and how to manage patients with specific urogynaecological conditions.

Paediatric Nephro-Urology Module 2025

The paediatric nephro-urology course is a primarily virtual module. It consists of four core learning blocks with two additional optional learning blocks. The focus of this course is to deepen the students understanding of the pathology and pathophysiology of childhood nephro- urological conditions. Current treatment modalities and their implications in practice will be explored.

Royal College of Surgeons of Edinburgh: Core Skills in Urology Course Module 1 & 2

This two-day course aimed at CT2 - ST4 level trainees uses lectures, tutorial discussion groups and practical sessions with a variety of 'hands on' models. The course aims to provide junior urology trainees with hands on practical training in basic endoscopic urological surgery offering the opportunity for practice that will augment local training programmes.

BPH therapy: how to find one’s way through the maze?

This communication is from the Young Academic Urologists (YAU) group of the European Association of Urologists (EAU). A purpose-built questionnaire of current practice was sent to 2000 members, of which 637 responded (68% were aged 50 or younger). Alpha blockers...

Intravesical glycosaminoglycan analogue instillations for recurrent cystitis

Introduction The symptoms of recurrent cystitis can be triggered by inflammatory or infective causes. Bladder pain syndrome (BPS) and bacterial recurrent lower urinary tract infection can both present with symptoms of recurrent cystitis and cause significant morbidity in affected individuals....

Tissue-based biomarkers steering clinical decisions in patients with urothelial cancer

Biomarkers play an essential role in the diagnosis and treatment of urothelial cancer (UC), with PD-L1, FGFR, and MMR proteins being the most clinically established. These biomarkers, derived from histological specimens, guide therapeutic decisions for bladder cancer (BCa) and upper...

The Nurse Practitioner in Urology

This book is designed to meet the needs of nurse practitioners, advanced practice nurses and physician assistants working in urology in the US where Advanced Practice Certification, although not mandatory, is highly sought after by employers and service users alike....

Kidney stones in pregnancy

Urolithiasis related complications are estimated to affect between 1:200 and 1:2000 pregnancies [1,2]. With around 825,000 conceptions in England and Wales in 2021 [3], this represents an uncommon but not rare occurrence. What is normally a straightforward pathway for a...

Use of Clavien-Dindo classification in urology part 1 – pelvic surgery

There is no widely accepted system to classify postoperative complications. It is necessary to compare the outcome and complications while validating a new surgical procedure or one of the surgical approaches of a particular condition. Several parameters have long been...

Neuroendocrine bladder tumour

A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...

Challenging Cases in Urological Surgery: Cases With Expert Commentary (Challenging Concepts)

The authors’ intention with this book is to provide a consensus on a number of common, challenging and controversial topics in urology, which are examined from a multidisciplinary approach with insights from expert opinion and current evidence. Challenging Cases in...

Performance status may alter outcomes in those treated with abiraterone

The drug therapies available for those with metastatic castrate-resistant prostate cancer have increased over the past few years. Abiraterone, a CYP17 inhibitor, has been proven effective in phase three trials, however those with poor performance status were largely under-represented in...